Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Orexo Ab (ORXOF)

Orexo Ab (ORXOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 12.26
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.2300 unch
on 12/26/25
3.2300 unch
on 12/26/25
N/A (+5.90%)
since 10/28/25
3-Month
3.0500 +5.90%
on 10/28/25
3.2300 unch
on 12/26/25
+0.3300 (+11.38%)
since 09/26/25

Most Recent Stories

More News
Orexo AB to Present Q3 2025 Interim Report and Project Updates

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Orexo AB...

ORXOF : 3.2300 (+5.90%)
Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication

UPPSALA, Sweden , Sept. 5, 2025 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announced positive pharmacokinetic in-vivo data for a powder-based intranasal semaglutide...

ORXOY : 2.6000 (-13.33%)
ORXOF : 3.2300 (+5.90%)

Business Summary

Orexo AB is a pharmaceutical company. It develops and improves products and treatments based on proprietary drug delivery technology. Its main products are Abstral, Edluar, Diabact UBT, and Heliprobe System. Abstral is a drug that provides fast and effective treatment of breakthrough pain in cancer patients....

See More

Key Turning Points

3rd Resistance Point 3.2300
2nd Resistance Point 3.2300
1st Resistance Point 3.2300
Last Price 3.2300
1st Support Level 3.2300
2nd Support Level 3.2300
3rd Support Level 3.2300

See More

52-Week High 3.2300
Last Price 3.2300
Fibonacci 61.8% 2.7219
Fibonacci 50% 2.5650
Fibonacci 38.2% 2.4081
52-Week Low 1.9000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar